In the field of analytical chemistry and proteomic research, high-quality peptide standards serve as the backbone for accurate mass spectrometry (MS) calibration. My personal experience working with laboratory standards has highlighted the importance of precision when dealing with specific sequences like the fibrinopeptide B sequence. Whether you are calibrating an instrument or studying protein interaction dynamics, understanding the structural nuances of these molecules is essential.
The Composition of the Fibrinopeptide B Sequence
The fibrinopeptide B (FPB) molecule is a critical polypeptide fragment. Research cons Glu1 -Fibrinopeptide B = 90 HPLC 103213-49-6 istently demonstrates that fibrinopeptides B are small polypeptides cleaved from the Bβ chain of fibrinogen by the enzyme thrombin. This process is a fundamental step in the conversion of fibrinogen to fibrin, which is of great interest in biochemical studies.
When sourcing these standards, you will frequently encounter the [Glu1]-Fibrinopeptide B variant. This specific form is derived from fibrinopeptide B amino acid residues 1-14. The standard Sequence (3-letter): Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH Sequence (1-letter): EGVNDNEEGFFSAR-OH Storage: -20 °C or below. Fibrinopeptide EGVNDNEEGFFSAR sequence is widely utilized due to its predictable monoisotopic mass of 1569.65 Da. Under controlled acidic conditions, this peptide produces a reliable +1 ion (m/z 1570.6) and a +2 ion, making it a gold standard for mass spec calibration.
Structural Variations and Nomenclature
Navigating the literature requires attention to detail regarding the N-terminus. You may see the sequence represented as:
* 1-Letter Sequence: EGVNDNEEGFFSAR-OH
* Alternative N-Terminus: (Glp)-GVNDNEEGFFSAR or Pyr-GVNDNEEGFFSAR
The Glp-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH notation refers to the pyroglutamate modification often found in native samples. Whether you are using the [Glu1] Fibrinopeptide B, Human variant or the modified version, both are vital for ensuring that your Fibrinogen beta chain research remains accurate and reproducible.
Biological Context and Research Applications
It is widely understood that fibrinopeptides A and B are crucial for blood clot formation. Their release by thrombin exposes polymerization sites that facilitate the assembly of fibrin monomers. I find that when discussing the fibrinopeptide B cleavage process, it is helpful to look at the B knob sequence, Gly-His-Arg, and Glu397 and Name: Fibrinopeptide B, human · Sequence: (Glp)-GVNDNEEGFFSAR · CAS Number: [36024-23-6] · Formula: C66H93N19O · Characteristics: None · Reference: None. Asp398 interactions, which dictate the stability of the resulting fibrin network.
Furthermore, the fibrinogen Bb1–14 fibrinopeptide segment is often studied for its role in modulating protein-protein interactions. Researchers focusing on the FGB (Fibrinogen Beta Chain) gene often utilize these peptides to understand how structural variations might impact protein function in a controlled, in vitro environment.
Best Practices for Handling Peptide Standards
From my experience in the lab, maintaining the integrity of these peptides is paramount:
1. Storage: Always store your fibrinopeptide B standards at -20 °C or below to prevent degradation.
2. Solubility: Ensure the [Glu1]-Fibrinopeptide B | CAS NO.:103213-49-6 peptide is fully reconstituted according to the manufacturer’s instructions, typically using high-purity water or buffer solutions.
3. Validation: Given that GVNDNEEGF is a recurring Fibrinopeptide B human motif within the sequence (one-letter code), Pyr-GVNDNEEGFFSAR, verify your mass spec results against the known theoretical mass to confirm the purity of your standard.
By utilizing high-purity [Glu1]-Fibrinopeptide B and adhering to strict handling protocols, researchers can ensure that their data remains robust. This peptide remains a c What is the role of Fibrinopeptide A and ornerstone for anyone working with mass spectrometry standards or investigating t Fibrinopeptide B, human he mechanical properties of fibrinogen-derived structures.